SCHEMBL18738859

SCHEMBL18738859

CO[N+](=O)c1cc(CSC)cc(OCCCCO)c1

nearest known ligand 0.32

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 8/20 0.32
▸ CNR2 P34972 7/20 0.32
▸ TP53 P04637 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ POLB P06746 1/20 0.30
▸ PLA2G2A P14555 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18738841 0.96 CNR1 (0.31) CNR1CNR2
SCHEMBL17164357 0.88 CHRNB4 (0.37) —
SCHEMBL21854579 0.87 MAPT (0.37) —
SCHEMBL17164367 0.84 S1PR4 (0.38) —
SCHEMBL18458344 0.79 TP53 (0.48) TP53ALOX15POLB
SCHEMBL18458781 0.74 TP53 (0.45) TP53ALOX15POLB
SCHEMBL20522004 0.74 MAPT (0.39) —
SCHEMBL28108700 0.74 PPARA (0.42) CNR1CNR2
SCHEMBL18738729 0.73 HSP90AB1 (0.37) —
SCHEMBL20521493 0.73 MAPT (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3129387-B1 NOVEL MACROCYCLIC COMPOUNDS Bayer Pharma AG (DE) 2019-06-26 — — EP disclosed
WO-2017060322-A2 PTEFB-INHIBITOR-ADC BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-04-13 — — WO disclosed
Send feedback